Clinical Trial Update: Early Dexmedetomidine and Sympathetic Regulation in Sepsis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating early dexmedetomidine for sympathetic regulation in sepsis and septic shock, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Sichuan Academy of Medical Sciences | Conditions: Sepsis, Septic Shock | Phase 4 | Status: NOT_YET_RECRUITING